PubRank

Martial G Bourassa

Author PubWeight™ 43.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008 6.17
2 Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005 4.06
3 Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002 3.47
4 Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet 2004 3.40
5 Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 2005 2.78
6 Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 2003 2.16
7 Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation 2003 1.69
8 Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 2004 1.62
9 Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004 1.32
10 Coronary heart disease in patients with diabetes: part II: recent advances in coronary revascularization. J Am Coll Cardiol 2007 1.23
11 Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management. J Am Coll Cardiol 2007 1.22
12 What is the economic value of digoxin therapy in congestive heart failure patients? Results from the DIG trial. J Card Fail 2006 1.12
13 Effects of AGI-1067 and probucol after percutaneous coronary interventions. Circulation 2003 1.09
14 Long-term survival differences among low-anxious, high-anxious and repressive copers enrolled in the Montreal heart attack readjustment trial. Psychosom Med 2002 1.06
15 The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease. Am Heart J 2006 1.04
16 Usefulness of self-reported leisure-time physical activity to predict long-term survival in patients with coronary heart disease. Am J Cardiol 2008 1.01
17 Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry. Am Heart J 2002 0.93
18 Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials. Am Heart J 2006 0.90
19 Resting heart rate and metabolic syndrome in patients with diabetes and coronary artery disease in bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial. Prev Cardiol 2010 0.84
20 Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease. Coron Artery Dis 2003 0.83
21 Long-term rates of cardiovascular events in patients with the metabolic syndrome according to severity of coronary-angiographic alterations. Coron Artery Dis 2009 0.81
22 Heart rate recovery after exercise and long-term prognosis in patients with coronary artery disease. Can J Cardiol 2012 0.80
23 Patients with coronary artery disease unsuitable for revascularization: definition, general principles, and a classification. Can J Cardiol 2012 0.80
24 Fasting but not postprandial (postmeal) glycemia predicts the risk of death in subjects with coronary artery disease. Can J Cardiol 2007 0.78
25 Temporal increases in subclinical levels of inflammation are associated with adverse clinical outcomes in patients with left ventricular dysfunction. J Card Fail 2006 0.78
26 Evaluation and risk stratification of acute coronary syndromes using a low cut-off level of cardiac troponin T, combined with CK-MB mass determination. Clin Biochem 2004 0.77
27 Differential influence of diabetes mellitus on increased jeopardized myocardium after initial angioplasty or bypass surgery: bypass angioplasty revascularization investigation. Circulation 2002 0.76
28 Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD. Can J Cardiol 2008 0.75
29 Angiotensin II inhibition and prevention of atrial fibrillation and stroke. J Am Coll Cardiol 2005 0.75
30 Classification and risk stratification of patients with acute chest pain using a low discriminatory level of cardiac troponin T. Clin Cardiol 2004 0.75
31 Incidence, coronary risk profile and angiographic characteristics of prediabetic and diabetic patients in a population with ischemic heart disease. Can J Cardiol 2003 0.75